Sally Beauty-SBH-Made $1.69 for 2024, estimates for 2025-$1.83. Trading around $9 or 4.9X forward earnings.

Synchronoss-SNCR. Made $1.63 in 2024, $.94 in Q4 alone. Trading at about $10. 6X 2024 EPS.

NEXXAN-NEXN. Made $.93 for 2024. More next year. Has $2.75 in net cash. Trading around $8. Trading at 5.6X EPS, net of cash.

Perion-PERI. Has $8.08 per share in net cash. Expected to make about $1 a share in 2025. Trading around $8.65 and a PE net of cash of less then 1.

Value stocks are still being shunned and silly valuations abound. I still hold PERI which has $8.08 a share in cash and is making around $1 a share and is trading at $8.09. VNDA has $6.43 a share in cash, operating at breakeven, has a robust drug pipeline and is trading at $4.76 a share, ARAY had its best quarter in 3 years and after climbing to $2.95 a share is back below $2 at $1.99. The list goes on and on. I am really not buying anything new and am still trying to liquidate my old holdings.